| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.28B | 18.38B | 19.85B | 21.66B | 18.45B | 18.45B |
| Gross Profit | 5.10B | 14.23B | 14.58B | 13.04B | 12.35B | 12.35B |
| EBITDA | 7.25B | 7.63B | 6.83B | 7.25B | 6.43B | 6.43B |
| Net Income | 2.83B | 2.90B | 2.29B | 7.80B | 2.35B | 2.35B |
Balance Sheet | ||||||
| Total Assets | 103.76B | 106.74B | 98.33B | 92.70B | 94.86B | 67.22B |
| Cash, Cash Equivalents and Short-Term Investments | 4.06B | 6.93B | 4.25B | 2.73B | 3.33B | 2.49B |
| Total Debt | 45.91B | 47.54B | 47.07B | 42.98B | 45.47B | 31.22B |
| Total Liabilities | 66.54B | 68.92B | 68.43B | 63.13B | 71.00B | 47.36B |
| Stockholders Equity | 37.19B | 37.80B | 29.87B | 29.54B | 23.83B | 19.84B |
Cash Flow | ||||||
| Free Cash Flow | -2.87B | -3.39B | -1.27B | -585.92M | 340.31M | -382.67M |
| Operating Cash Flow | 6.24B | 5.27B | 5.64B | 5.57B | 5.65B | 3.59B |
| Investing Cash Flow | -4.99B | -10.87B | -7.83B | -14.60M | -14.79B | -4.92B |
| Financing Cash Flow | -1.60B | 6.36B | 2.62B | -5.59B | 9.18B | 1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $70.37B | 16.71 | 12.06% | 3.25% | 7.66% | 37.42% | |
74 Outperform | $81.42B | 21.62 | 7.66% | 4.03% | -7.06% | 38.21% | |
71 Outperform | $101.09B | 18.33 | 9.69% | 3.61% | 4.80% | 14.44% | |
66 Neutral | $106.96B | 22.16 | 12.50% | 3.40% | 9.40% | -6.05% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | $49.43B | 15.92 | 9.87% | 3.68% | 6.07% | 15.20% | |
63 Neutral | $53.50B | 16.69 | 10.77% | 4.59% | 12.72% | 4.90% |